Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta variable 27 is a variable region segment of the beta chain of the T cell receptor (TCR), a heterodimeric surface receptor critical for antigen-specific immune responses of T lymphocytes. TRBV27 contributes to the antigen recognition domain of TCRs, enabling T cells to recognize peptide–MHC (major histocompatibility complex) complexes presented by antigen-presenting cells. Recognition of these complexes is essential to initiate adaptive immune responses, including the activation and differentiation of T cells. Upon antigen binding, the TCR complex signals through associated CD3 molecules, triggering phosphorylation events and the assembly of intracellular signaling complexes. This results in the activation of several pathways (including MAP kinase and NF-κB), promoting gene expression changes required for T cell activation, proliferation, and differentiation. Diversity in TRBV usage underlies T cell repertoire variability, which is crucial for effective immunity and tolerance[1][2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta variable 27 (TRBV27).